Do NSAIDs Prevent Colorectal Cancer?
Author:
Open Access
- 1 January 2000
- journal article
- review article
- Published by Hindawi Limited in Canadian Journal of Gastroenterology and Hepatology
- Vol. 14 (4) , 299-307
Abstract
There is increasing evidence to suggest that acetylsalicylic acid (ASA) and other nonsteroidal anti-inflammatory drugs (NSAIDs) reduce the risk of colorectal cancer. This observation is supported by animal studies that show fewer tumours per animal and fewer animals with tumours after administration of several different NSAIDs. Studies in humans consistently support this hypothesis. Intervention data from familial adenomatosis coli establish that the process of human colonic adenoma polyp formation is affected. Supportive evidence comes from 21 of 23 human studies -- both case-control and cohort. The reduced risk has been found in men and women, for cancers of the colon and the rectum and for the use of both ASA and the other NSAIDs. Earlier detection of lesions as a result of drug-induced bleeding does not seem to account for these findings. The molecular mechanisms responsible for the chemopreventive action of this class of drugs is not completely established. Protection may affect several pathways, including cell cycle arrest and induction of apoptosis. Because of the consistency of epidemiological, clinical and experimental data, there is no need for further placebo trials. At the same time, there is a need to establish the dose, duration and frequency of use required for cancer-preventive activity.Keywords
This publication has 60 references indexed in Scilit:
- Use of Nonsteroidal Anti-inflammatory Drugs and Incidence of Colorectal CancerArchives of internal medicine (1960), 1999
- Rheumatoid arthritis and the risk of malignancyArthritis & Rheumatism, 1997
- Nonsteroidal Antiinflammatory Drugs Inhibit the Proliferation of Colon Adenocarcinoma Cells: Effects on Cell Cycle and ApoptosisExperimental Cell Research, 1996
- Aspirin and Related Nonsteroidal Anti-inflammatory Drugs as Chemopreventive Agents Against Colon CancerPreventive Medicine, 1995
- Inhibition of aberrant crypt growth by non‐steroidal anti‐inflammatory agents and differentiation agents in the rat colonInternational Journal of Cancer, 1995
- Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase?Journal of Cellular Biochemistry, 1995
- Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposisBritish Journal of Surgery, 1993
- Aspirin use, cancer, and polyps of the large bowelCancer, 1993
- Sulindac for polyposis of the colonJournal of Surgical Oncology, 1983
- Indomethacin and ascorbate inhibit desmoid tumorsJournal of Surgical Oncology, 1980